US 11401322
Immunoglobulin chimeric monomer-dimer hybrids
granted A61KA61K38/00A61K47/60
Quick answer
US patent 11401322 (Immunoglobulin chimeric monomer-dimer hybrids) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/642, A61K47/68